Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Cantor Fitzgerald
Fuji
Colorcon
Covington
Chinese Patent Office
Farmers Insurance
Argus Health
Johnson and Johnson

Generated: August 16, 2018

DrugPatentWatch Database Preview

Epinephrine bitartrate; prilocaine hydrochloride - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for epinephrine bitartrate; prilocaine hydrochloride and what is the scope of epinephrine bitartrate; prilocaine hydrochloride freedom to operate?

Epinephrine bitartrate; prilocaine hydrochloride is the generic ingredient in three branded drugs marketed by Astrazeneca, Dentsply Pharm, and Septodont Inc, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are nineteen drug master file entries for epinephrine bitartrate; prilocaine hydrochloride. Two suppliers are listed for this compound.

Summary for epinephrine bitartrate; prilocaine hydrochloride
Pharmacology for epinephrine bitartrate; prilocaine hydrochloride

US Patents and Regulatory Information for epinephrine bitartrate; prilocaine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dentsply Pharm CITANEST FORTE DENTAL epinephrine bitartrate; prilocaine hydrochloride INJECTABLE;INJECTION 021383-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Septodont Inc PRILOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE epinephrine bitartrate; prilocaine hydrochloride INJECTABLE;INJECTION 078959-001 Aug 30, 2011 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Astrazeneca CITANEST FORTE epinephrine bitartrate; prilocaine hydrochloride INJECTABLE;INJECTION 014763-008 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Teva
Daiichi Sankyo
US Army
Covington
Mallinckrodt
Merck
Dow
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.